OBJECTIVEThe presence of carotid plaques is associated with future cardiovascular events, with local plaque composition being an independent outcome predictor. We examined the association between ultrasonographically determined carotid plaque calcification and incident major adverse cardiovascular events (MACE) and death in type 2 diabetes (T2D).
RESEARCH DESIGN AND METHODSWe enrolled 581 patients with T2D who underwent routine carotid ultrasonography. Plaques were classified as echolucent (lipid rich), heterogenous, and echogenic (calcific). We collected demographic, anthropometric, and clinical data at baseline and followed the patients for up to 9 years.
RESULTSPlaques were detected in 81.8% of the patients (echolucent in 16.4%, heterogenous in 43.2%, and echogenic in 22.2%). During follow-up (4.3 6 0.1 years), 58 deaths (27 cardiovascular) and 236 fatal and nonfatal MACE occurred. In univariate analyses, presence versus absence of any carotid plaque was associated with incident MACE, and the hazard ratio (95% CI) progressively increased from echolucent (1.97 [0.93-3.44]), to heterogeneous (3.10 [2.09-4.23]), to echogenic (3.71 [2.09-5.59]) plaques. Compared with echolucent plaques, echogenic plaques were associated with incident MACE independently from confounders. This association was attenuated after adjusting for the degree of stenosis, but in patients with stenosis £30%, echogenic plaque type still predicted total and atherosclerotic MACE, even after further adjusting for mean intima-media thickness.
CONCLUSIONSIn T2D, carotid plaque calcification predicts MACE, especially in patients with a low degree of stenosis. The biology of atherosclerotic calcification in diabetes needs to be further elucidated to understand the basis of this association.Atherosclerosis is a common complication of diabetes, driving severe morbidity and mortality. Atherosclerotic plaques are complex structures with multiple tissues and cell types that differentially contribute to lesion vulnerability (1). In populationbased longitudinal studies, atherosclerotic plaque characteristics have been shown to predict atherosclerosis progression at a systemic level, being associated with incident cardio-and cerebrovascular events (2-7). Based on ultrasonographic plaque characterization, echolucent (lipid-rich) plaques seem to be a better predictor of stroke and cardiovascular events than echogenic or echorich plaques containing